Keywords: cv, therapeutics, shares, slump, analyst, note, been

CV Therapeutics shares slump on analyst note

Article | 03 June 2002

Print This

Shares in CV Therapeutics have been hit hard by a Morgan Stanley reportclaiming that the company's drug for angina, ranolazine, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in